Effective cancer care requires holistic benefits approach

Subar, Milayna
March 2011
Employee Benefit News;Mar2011, Vol. 25 Issue 3, p46
The article focuses on effective cancer care through the holistic benifit programs of employers. It notes the encouragement of doctors by managed care organizations to follow clinical protocols, including the use of genetic screening tests in selected circumstances. The effect of evolution on oncology care to the lifestyle of cancer patients is also discussed.


Related Articles

  • Employment Outcomes of Men Treated for Prostate Cancer. Bradley, Cathy J.; Neumark, David; Zhehui Luo; Bednarek, Heather; Schenk, Maryjean // JNCI: Journal of the National Cancer Institute;7/6/2005, Vol. 97 Issue 13, p958 

    Background: Some organizations recommend prostate cancer screening for men younger than age 65 years, many of whom will be employed when they are diagnosed and treated for prostate cancer. Yet little is known about how prostate cancer and its treatment affect men's employment status....

  • Update on Direct-to-Consumer Marketing in Oncology. Abel, Gregpory A.; Gray, Stacy W. // Journal of Oncology Practice;Mar2012, Vol. 8 Issue 2, p124 

    The authors comment on the aspects of direct-to-consumer marketing (DTCM) of cancer-related goods and services in the U.S. They mention that DTCM has become a trend in the country particularly in oncology because of the changes in technological, cultural, and regulatory standards. They cite...

  • Florida Blue, Baptist Health South Florida and Advanced Medical Specialties Introduce Accountable Cancer Care Program.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article informs that Florida Blue, Florida's Blue Cross & Blue Shield Inc.'s company, has announced a joint collaboration with Baptist Health South Florida Inc. and Advanced Medical Specialties, an oncology practice. The collaboration has been made to provide the utmost in quality care for...

  • NYC gears up for the 21st annual breast cancer walk in Central Park. ARINDE, NAYABA // New York Amsterdam News;9/11 10th Anniversary Issue, p3 

    The article reports that the newspaper will be hosting the 21st annual Susan G. Komen Greater New York City Race for the Cure on September 18, 2011.

  • Vassar Cancer Care Center offers 'big-city' treatments.  // Hudson Valley Business Journal;02/01/99-02/08/99, Vol. 9 Issue 20, p16 

    Focuses on the cancer treatments offered at Vassar Brothers Hospital in Poughkeepsie, New York. Statistics on the incidence and prevalence of cancer; Progress in cancer treatment protocols; Tests on the anticancer drugs Tamoxifen and Fareston conducted at the hospital; Outpatient cancer...

  • Paclitaxel (Taxol) and Taxoid Derivates for Lung Cancer Treatment: Potential for Aerosol Delivery. Ajay Gautam; Nadezhda Koshkina // Current Cancer Drug Targets;Aug2003, Vol. 3 Issue 4, p287 

    Paclitaxel (PTX, Taxol) has revolutionized cancer treatment in the past decade and is recognized as one of the biggest advances in oncology medicine. In spite of the good clinical efficacy shown by PTX, there is still a growing need to achieve better safety and pharmacokinetic profile of PTX in...

  • Engineering Regulatory Elements for Conditionally-Replicative Adenoviruses. Yosef S. Haviv; David T. Curiel // Current Gene Therapy;Aug2003, Vol. 3 Issue 4, p357 

    Virus-mediated oncolysis is a rapidly growing field with the potential to dramatically alter the future of cancer therapy. Replication-selective viruses are superior to non-replicating vectors in several aspects, such as the amplification of the initial low-dose viral inoculum up to...

  • Moncrief sessions study cases pre-, not post-op. Letsche, Amber Lee // Fort Worth Business Press;12/7/2001, Vol. 14 Issue 33, p9 

    Reports on modality conferences of University of Texas Southewestern Moncrief Cancer Center oncologists and physicians. Review of prospective patients before treatment begins; Enhancement of patient care at Moncrief; Better understanding of patients' case management.

  • ONCOLOGIC INTRODUCES NEW CANCER TREATMENT.  // Biotech Business;Jun2001, Vol. 14 Issue 6, p5 

    Reports that Oncologic Inc. has successfully demonstrated the first step of its Oncologic Process for solid cancer treatment.


Read the Article


Sign out of this library

Other Topics